Our findings reveal a novel mechanistic pathway where AGBL4 enhances GBM malignancy primarily through modulation of MMP-1 expression, which in turn influences the inflammatory response pathways within the tumor microenvironment (Figure 11). This evidence concerns the gene AGBL4 and neoplasm.